The Assessment of Single-Dose Safety,Tolerability, Pharmacokinetics and Pharmacodynamic of Globalagliatin Hydrochloride

Clinical trial NCT03171623 · COMPLETED

Trial details

NCT number: NCT03171623
Sponsor: Yabao Pharmaceutical Group
Status: COMPLETED
Phase: Phase 1
Study type: INTERVENTIONAL

Hyperglycaemia (Diabetic)Healthy Volunteers

Start date: 2017-04-05
Primary completion: 2017-09-25
Enrollment: 44

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.